Sequential Prefrontal Alpha-Theta Neurofeedback on Abstinence Self-Efficacy, Mindfulness, and EEG in Alcohol Use Disorder
NFB-AUD
Effects of Sequential Prefrontal Alpha-Theta Neurofeedback Training on Abstinence Self-Efficacy, Mindfulness, and EEG in Alcohol Use Disorder
1 other identifier
interventional
17
1 country
1
Brief Summary
This study examined the effects of sequential prefrontal alpha-theta neurofeedback training on abstinence self-efficacy, mindfulness, and brain electroencephalography (EEG) activity in adults with Alcohol Use Disorder (AUD). Participants in the experimental group received 24 sessions of neurofeedback over 8 weeks (3 sessions per week, 30 minutes per session), while a control group received no intervention. EEG and self-report measures were assessed at baseline and post-intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 25, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 25, 2024
CompletedFirst Submitted
Initial submission to the registry
May 5, 2026
CompletedFirst Posted
Study publicly available on registry
May 13, 2026
CompletedMay 13, 2026
May 1, 2026
3 months
May 5, 2026
May 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Abstinence Self-Efficacy
Total score on the Alcohol Abstinence Self-Efficacy Scale (AASE; Korean adaptation), a 20-item scale with four subscales (Negative Affect, Social/Positive Emotions, Physical and Other Concerns, Withdrawal and Urges), each rated 0-4; higher scores indicate greater confidence in maintaining abstinence.
Baseline (Week 0) and post-intervention (Week 8)
Secondary Outcomes (2)
Mindfulness
Baseline (Week 0) and post-intervention (Week 8)
EEG Relative Power
Baseline (Week 0) and post-intervention (Week 8)
Study Arms (2)
Sequential Prefrontal Alpha-Theta Neurofeedback
EXPERIMENTAL24 sessions of sequential prefrontal alpha-theta neurofeedback training over 8 weeks (3 sessions/week, 30 min/session). Each session: 5 min alpha feedback (8-12 hertz \[Hz\]) followed by 25 min theta feedback (4-7 Hz) at Fp1/Fp2, delivered via ocean wave and birdsong audio while eyes closed. Device: Power Nap (Neuro21, Korea).
Control - No Intervention
NO INTERVENTIONParticipants continued usual daily activities for 8 weeks without any intervention. Pre- and post-test assessments (EEG and self-report measures) were conducted.
Interventions
Operant conditioning-based neurofeedback: 5 min alpha (8-12 Hz) + 25 min theta (4-7 Hz) at prefrontal sites Fp1/Fp2 per session; 24 sessions over 8 weeks supervised by a certified practitioner. Audio feedback (ocean waves for alpha, birdsong for theta) delivered via Power Nap device (Neuro21, Korea) while participants remained eyes-closed and seated.
Eligibility Criteria
You may qualify if:
- Adults diagnosed with Alcohol Use Disorder (AUD) according to Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) criteria
- Alcohol Use Disorders Identification Test-Korean (AUDIT-K) score \>= 20 (males) or \>= 10 (females) indicating high-risk drinking
- Voluntary written informed consent
You may not qualify if:
- Sensory impairment (visual or auditory)
- Diagnosis of intellectual disability
- Current use of antipsychotics, central nervous system stimulants, or sedatives
- Active neurological conditions (e.g., epilepsy, recent traumatic brain injury)
- Severe psychiatric comorbidities (e.g., active psychosis) contraindicated for EEG-based neurofeedback
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Neurofeedback Training Centre
Seoul, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 5, 2026
First Posted
May 13, 2026
Study Start
July 1, 2024
Primary Completion
September 25, 2024
Study Completion
September 25, 2024
Last Updated
May 13, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share